Marketing Content

Marketing Content Generation for Talosix EDC

Purpose

Create compelling marketing content that positions Talosix as a leader in clinical trial EDC technology. All content must resonate with clinical operations professionals, data managers, and trial sponsors while maintaining regulatory awareness and evidence-based credibility.

Target Audiences

• Clinical Operations Directors — Concerned with study timelines, site performance, budget control
• Clinical Data Managers — Focused on data quality, edit check logic, CDISC compliance, query resolution
• CRO Executives — Evaluating EDC platforms for multi-sponsor use, scalability, speed of deployment
• Site Coordinators/CRAs — Want intuitive interfaces, reduced double-entry, offline capability
• IT/Validation Teams — Need 21 CFR Part 11 compliance, audit trails, integration APIs
• Biostatisticians — Care about data export formats, SDTM mapping, analysis-ready datasets

Content Types and Guidelines

Blog Posts

Structure:

1. Hook with a specific clinical trial pain point or industry trend
2. Contextualize the problem with data or real-world scenario
3. Present insight or solution approach
4. Connect to Talosix capability without hard selling
5. Close with actionable takeaway or CTA

Tone: Authoritative but accessible. Avoid jargon overload — explain acronyms on first use. Write at a level that a clinical operations professional with 5+ years experience finds credible.

Length: 800-1,200 words for standard posts. 1,500-2,000 for pillar content.

SEO requirements:

• Primary keyword in title, H1, first 100 words, and meta description
• 2-3 secondary keywords distributed naturally
• Internal links to related Talosix pages (product, resources, other blog posts)
• Meta description: 150-160 characters, include primary keyword and value proposition

Example topics:

• "How Risk-Based Monitoring Changes EDC Requirements"
• "5 Data Quality Metrics Every Clinical Data Manager Should Track"
• "Decentralized Trials: What Your EDC Platform Must Support"
• "CDISC CDASH 3.0: What It Means for Your eCRF Design"

Thought Leadership Articles

Structure:

1. Open with a bold, defensible perspective on an industry trend
2. Support with regulatory references, published data, or market analysis
3. Explore implications for clinical operations teams
4. Offer a forward-looking recommendation
5. Position Talosix philosophy (not product pitch) as aligned with the direction

Tone: Executive-level. Cite ICH guidelines, FDA guidance documents, EMA publications where relevant. Reference industry benchmarks (Tufts CSDD, DIA publications, Applied Clinical Trials).

Length: 1,200-2,000 words.

Placement targets: Applied Clinical Trials, Clinical Leader, ACRP blog, DIA Global Forum, LinkedIn articles.

Social Media Content

LinkedIn (primary channel):

• Post length: 150-300 words for engagement posts, 50-100 for link shares
• Lead with a provocative question or surprising statistic
• Use line breaks for readability
• Include 3-5 relevant hashtags: #ClinicalTrials #EDC #ClinicalData #eCRF #CDISC #DrugDevelopment
• Tag relevant organizations (DIA, ACRP, SCDM) when appropriate

Twitter/X:

• 280 character limit per tweet
• Use threads for complex topics (3-5 tweets)
• Include one hashtag maximum per tweet for professional tone
• Link to blog posts or landing pages

Content pillars for social:

1. Industry insights and trend commentary
2. Product capability highlights (feature-focused, not salesy)
3. Customer success signals (anonymized metrics, testimonials)
4. Team and culture (humanize the brand)
5. Event presence and speaking engagements

Clinical Trial Industry Tone Guide

Do:

• Use evidence-based claims with specific metrics where possible
• Reference regulatory frameworks (ICH-GCP, 21 CFR Part 11, GDPR, EU CTR)
• Acknowledge complexity of clinical trial operations
• Demonstrate understanding of validation requirements
• Respect the seriousness of patient safety and data integrity

Do Not:

• Make unsubstantiated claims about regulatory compliance
• Use consumer SaaS marketing language ("disrupt," "revolutionary," "game-changer")
• Oversimplify the clinical trial process
• Promise specific regulatory outcomes
• Use patient data or identifiable trial information without explicit permission

Preferred Terminology:

• "Electronic Data Capture" not "data entry system"
• "eCRF" not "electronic form" (in clinical context)
• "Study build" not "form creation"
• "Edit checks" not "validation rules" (in EDC context)
• "Query management" not "error handling"
• "21 CFR Part 11 compliant" not "FDA approved" (for software)

SEO Keyword Strategy

Primary Keywords (high intent):

• clinical trial EDC software
• electronic data capture system
• eCRF design software
• clinical data management system (CDMS)
• EDC platform for clinical trials

Secondary Keywords (informational):

• clinical trial data collection
• eCRF best practices
• EDC system validation
• CDISC compliant EDC
• risk-based data management

Long-tail Keywords:

• "how to reduce clinical trial data entry errors"
• "EDC system for decentralized clinical trials"
• "CDASH compliant eCRF templates"
• "clinical trial data quality metrics"

Content Production Workflow

1. Brief: Define topic, target keyword, audience segment, funnel stage
2. Outline: Create structured outline with key points and supporting evidence
3. Draft: Write full draft following tone and structure guidelines
4. Review checkpoints:
   • Regulatory claim accuracy (no misleading compliance statements)
   • Brand voice consistency
   • SEO element completion (meta, headings, links)
   • CTA alignment with campaign goals
5. Approval: Marketing lead sign-off; legal review if regulatory claims included
6. Publish: Add to CMS with proper metadata, categories, and tracking

Output Format

When generating content, provide:

• Title with primary keyword
• Meta description (150-160 chars)
• Full content with H2/H3 structure
• Suggested internal links
• Social media promotion snippets (LinkedIn + Twitter)
• Recommended publication date considerations (avoid major conference weeks unless relevant)